Table 2 Comparison of two groups by using the EORTC QLQ C30 and BR23 questionnaires

Global health status^a

83.3 (0–100)

83.3 (33.3–100)

0.21

Physical function^a

86.6 (26.6–100)

93.3 (33.3–100)

0.012

Role function^a

100 (0–100)

100 (50–100)

0.053

Emotional function^a

83.3 (0–100)

83.3 (33–100)

0.705

Cognitive function^a

100 (0–100)

100 (0–100)

0.175

Social function^a

83.3 (0–100)

66.6 (17–100)

0.205

Financial problems^b

33.3 (0–100)

33.3 (0–100)

0.58

Dyspnea^b

0 (0–100)

0 (0–66.6)

0.483

Pain^b

16.6 (0–100)

16.6 (0–100)

0.155

Nausea/vomiting^b

0 (0–66.6)/3.04

0 (0–16.6)/0.29

0.024

Fatigue^b

33.3 (0–100)

33.3 (0–88.8)

0.214

Sleep disturbances^b

0 (0–100)/21.1

0 (0–100)/14.8

0.057

Appetite loss^b

0 (0–100)

0 (0–66.6)

0.384

Constipation^b

0 (0–100)

0 (0–100)

0.663

Diarrhea^b

0 (0–100)

0 (0–67)

0.155

Systemic therapy side effects^b

11 (7–28)

11 (7–24)

0.858

Arm symptoms^b

22.2 (0–100)

22.2 (0–78)

0.511

Breast symptoms^b

8.3 (0–100)

0 (0–67)

0.055

Upset by hair loss^b

6.38 ± 15.23

4.35 ± 15.04

0.440

Body image^a

75 (0–100)

58.3 (0–100)

0.000

Future perspective^a

66.6 (0–100)

66.6 (0–100)

0.926

Sexual function^a

4 (1–12)

4 (2–12)

0.165

Sexual enjoyment^a

5.34 ± 14.33

3.37 ± 12.24

0.298